Cancer cells have been shown to express β-adrenergic receptors (βARs) (30), and adrenergic signaling has been linked to tumorigenesis and cancer progression through promotion of processes such as DNA repair, oncogene activation, inflammation and immune response, angiogenesis, survival, and epithelial-mesenchymal transition (29). This evidence concerns the gene CTBP1 and cancer.